http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105008348-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3e182c0c7bc69e566750a7c5d0bdda
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c75d8ce91b2076fd6ef1e2d42703c8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7242db50ad752d9bf2454b872008eac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b8e34297812490e3902ebf9403e981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74f93729c4dd023097811150aed93fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee8ed58044d9df7f40e2bd48f670319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294ab74bde8b0bfc678a4cc6cd4f3ac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef42c6483f342fe0ed2690216116ef0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07e9de3fbfb9877f83d3eca4418ef52e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c3c9e1266fcdf87ac88aaa07cf7efb1
publicationDate 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105008348-A
titleOfInvention Pyrazolylbenzo[D]imidazole Derivatives
abstract Compounds represented by formula (I) and acid addition salts thereof, wherein the hydrogen atoms shown to be connected to the pyrazole and benzimidazole rings are respectively connected to one of the nitrogen atoms of the pyrazole or benzimidazole rings; R represents -XQP, wherein X does not exist or represents -CH 2 -, -C(O)- or -C(O)NH-(CH 2 ) k -, wherein k is 0, 1 or 2; Q is selected from Q1, Q2 , Q3, Q4 and Q5, P does not exist or represents straight or branched C1-C3 alkyl, -(CH 2 ) l -NR 2 R 3 or -(CH 2 ) m -C(O)-NR 2 R 3 , wherein l and m independently represent 0, 1 or 2 , the condition is that when B in Q1 represents an oxygen atom, P does not exist; and R2 and R3 independently represent C1 or C2 alkyl, R2 and R 3 together with the nitrogen atom to which they are both attached form a 6-membered saturated heterocyclic ring, wherein one of the carbon atoms may optionally be replaced by -O-, -NH- or -N(C1-C2)alkyl. The compounds can be used in the treatment of cancer diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107698538-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107698538-A
priorityDate 2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006033943-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005009894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012074126-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136387459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465062587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431537012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163693089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431537163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432567192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90422255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90422184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90422167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467417520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431537029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82183722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425594583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90422489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424997159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465481367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163495114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163787542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136387422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468338255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465345051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430713773

Total number of triples: 57.